A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.

Fosså, S D

A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867. [electronic resource] - European journal of cancer & clinical oncology Feb 1989 - 389-90 p. digital

Publication Type: Journal Article

0277-5379

10.1016/0277-5379(89)90035-7 doi


Adult
Aged
Carcinoma, Transitional Cell--drug therapy
Drug Evaluation
Epirubicin--adverse effects
Female
Humans
Leukopenia--chemically induced
Male
Middle Aged
Nausea--chemically induced
Thrombocytopenia--chemically induced
Urinary Bladder Neoplasms--drug therapy